Reporter needs Roche/Plexxikon Phase III patients

› Forums › General Melanoma Community › Reporter needs Roche/Plexxikon Phase III patients

  • Post
    • July 28, 2010 at 9:36 pm
    mrf
    Keymaster

      I have been contacted by a national reporter interested in speaking with a couple of patients who are currently enrolled in the Phase III study of the BRAF inhibiter in development from Roche/Plexxikon.  This reporter wants to hear a patient’s perspective on the trial.  This is a great opportunity to have unfiltered patient input into the clinical trial process.

      If you are please send me an e-mail and I will forward it along to the reporter.

      Thanks

      Tim–MRF

      tturnham@melanoma.org

       

       

       

      I have been contacted by a national reporter interested in speaking with a couple of patients who are currently enrolled in the Phase III study of the BRAF inhibiter in development from Roche/Plexxikon.  This reporter wants to hear a patient’s perspective on the trial.  This is a great opportunity to have unfiltered patient input into the clinical trial process.

      If you are please send me an e-mail and I will forward it along to the reporter.

      Thanks

      Tim–MRF

      tturnham@melanoma.org

       

       

       

    Viewing 2 reply threads
    • Replies
    Viewing 2 reply threads
    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics